Theriva Biologics, Inc. Share Price
AMEX: TOVX | Micro CapTheriva Biologics, Inc. Stock Performance
Theriva Biologics, Inc. Share Price Today
As of 9 October 2026, Theriva Biologics, Inc.'s share price is $0.23. The stock opened at $0.23, compared to its previous close of $0.24. During today's trading session, Theriva Biologics, Inc.'s share price traded between $0.23 and $0.23, with an average price of $0.23. Over the past 52 weeks, the stock has recorded a high of $0.86 and a low of $0.17. In terms of performance, Theriva Biologics, Inc.'s share price has declined by 34.09% over the last six months and is down 25.16% on a year-on-year basis.
Theriva Biologics, Inc. Share Price Chart
Theriva Biologics, Inc. Quarterly Profit & Loss
All figures in USD
Theriva Biologics, Inc. Annual Profit & Loss
All figures in USD
About Theriva Biologics, Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
Theriva Biologics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.22 | $0.23 | +0.00% |
Sep 2026 | $0.24 | $0.23 | -9.45% |
Aug 2026 | $0.22 | $0.25 | +20.38% |
Jul 2026 | $0.25 | $0.21 | -16.60% |
Jun 2026 | $0.28 | $0.25 | -10.92% |
May 2026 | $0.36 | $0.28 | -19.32% |
Apr 2026 | $0.20 | $0.35 | +78.68% |
Mar 2026 | $0.19 | $0.20 | -1.01% |
Feb 2026 | $0.18 | $0.20 | +11.80% |
Jan 2026 | $0.20 | $0.18 | -13.59% |
Dec 2025 | $0.26 | $0.21 | -24.26% |
Nov 2025 | $0.31 | $0.27 | -12.26% |